Anzeige
Mehr »
Donnerstag, 31.07.2025 - Börsentäglich über 12.000 News
Geheime Millionen-Käufe in Bitcoin & Altcoins - ohne Wallet, ohne Risiko? Jetzt wird's spannend
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A143XJ | ISIN: US92915B1061 | Ticker-Symbol: VT6
Tradegate
30.07.25 | 20:56
3,058 Euro
+10,56 % +0,292
1-Jahres-Chart
VOYAGER THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
VOYAGER THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,9803,04030.07.
2,9663,06430.07.

Aktuelle News zur VOYAGER THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17.07.Baird reiterates Outperform rating on Voyager Therapeutics stock with $18 price target15
16.07.Voyager Therapeutics erweitert Alzheimer-Portfolio um APOE-Gentherapie6
16.07.Voyager Therapeutics unveils APOE-targeting Alzheimer's therapy program4
16.07.Voyager Therapeutics, Inc.: Voyager Adds Fourth Wholly-Owned Alzheimer's Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach145- New program combines IV-delivered TRACER capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delivering the protective APOE2 variant - - Voyager's wholly-owned...
► Artikel lesen
09.06.Voyager Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans5
VOYAGER THERAPEUTICS Aktie jetzt für 0€ handeln
05.06.Voyager Therapeutics, Inc. - 8-K, Current Report7
15.05.Voyager Therapeutics, Inc.: Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication315LEXINGTON, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced...
► Artikel lesen
06.05.Voyager Therapeutics, Inc.: Voyager Reports First Quarter 2025 Financial and Operating Results301- Tau silencing gene therapy VY1706 to be featured in oral presentation at ASGCT 2025; has shown up to 73% knockdown of tau mRNA in the CNS in NHPs following a single IV dose of 1.3e13 vg/kg - - Recent...
► Artikel lesen
06.05.Voyager Therapeutics, Inc. - 10-Q, Quarterly Report4
06.05.Voyager Therapeutics, Inc. - 8-K, Current Report1
28.04.Voyager Therapeutics, Inc.: Voyager Next-Generation CNS Capsids Featured at ASGCT 28th Annual Meeting2
08.04.7 Analysts Assess Voyager Therapeutics: What You Need To Know44
31.03.Voyager Therapeutics, Inc.: Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD 2025327- Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad brain distribution and liver de-targeting, in NHP study - - Preclinical...
► Artikel lesen
13.03.Canaccord cuts Voyager Therapeutics target to $12, keeps Buy rating4
13.03.H.C. Wainwright maintains $30 target on Voyager Therapeutics stock2
12.03.A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 4 Analysts5
12.03.Citi cuts Voyager Therapeutics target to $11, maintains Buy rating12
11.03.Voyager Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans1
11.03.Voyager Therapeutics, Inc.: Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results215- Tau silencing gene therapy VY1706 robustly reduced tau mRNA levels, with broad distribution, and was well-tolerated in NHP study; IND filing anticipated in 2026 - - Anti-tau antibody VY7523 was...
► Artikel lesen
11.03.Voyager Therapeutics GAAP EPS of -$0.59 misses by $0.21, revenue of $6.28M misses by $10.3M2
Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1